Strasbourg, France

Jérôme Steibel

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Université Louis Pasteur. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jérôme Steibel. Retrieved from https://idiyas.com/inventor/jérôme-steibel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jérôme Steibel

Introduction

Jérôme Steibel is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of pharmacy, particularly in medical imaging. His work focuses on the development of dendritic chelated compounds, which have important applications in pharmaceutical compositions.

Latest Patents

Jérôme Steibel holds a patent for "Dendritic chelated compounds, methods for making the same and pharmaceutical compositions containing the same." This invention relates to dendritic chelated compounds and methods for producing them. The compounds are designed to enhance medical imaging through the use of specific markers and chelating agents.

Career Highlights

Throughout his career, Jérôme has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Louis Pasteur. His experience in these organizations has contributed to his expertise in the field of pharmaceutical research and development.

Collaborations

Jérôme has collaborated with several professionals, including Delphine Felder-Flesch and Annabelle Bertin. These collaborations have further enriched his research and innovation efforts.

Conclusion

Jérôme Steibel's work in developing dendritic chelated compounds showcases his innovative spirit and dedication to advancing medical imaging technologies. His contributions are valuable to the pharmaceutical industry and highlight the importance of research in improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…